{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T00:48:38Z","timestamp":1761094118530,"version":"build-2065373602"},"reference-count":30,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2009,1,1]],"date-time":"2009-01-01T00:00:00Z","timestamp":1230768000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,1,1]],"date-time":"2009-01-01T00:00:00Z","timestamp":1230768000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,4,10]],"date-time":"2015-04-10T00:00:00Z","timestamp":1428624000000},"content-version":"vor","delay-in-days":2290,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["bbmt.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biology of Blood and Marrow Transplantation"],"published-print":{"date-parts":[[2009,1]]},"DOI":"10.1016\/j.bbmt.2008.10.015","type":"journal-article","created":{"date-parts":[[2009,1,14]],"date-time":"2009-01-14T04:25:10Z","timestamp":1231907110000},"page":"79-83","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"S","title":["Controversies of and Unique Issues in Hematopoietic Cell Transplantation for Infant Leukemia"],"prefix":"10.1016","volume":"15","author":[{"given":"Stephen P.","family":"Hunger","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K. Mignon","family":"Loh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K. Scott","family":"Baker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kirk R.","family":"Schultz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbmt.2008.10.015_bib1","series-title":"Program NCIS","article-title":"Cancer incidence and survival among children and adolescents: United States SEER Program 1975-1995","author":"Ries","year":"1999"},{"key":"10.1016\/j.bbmt.2008.10.015_bib2","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.bcmd.2007.07.005","article-title":"Insights from clinical studies into the role of the MLL gene in infant and childhood leukemia","volume":"40","author":"Chowdhury","year":"2008","journal-title":"Blood Cells Mol Dis"},{"key":"10.1016\/j.bbmt.2008.10.015_bib3","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/S0140-6736(07)61126-X","article-title":"A treatment protocol for infants younger than 1 year with acute lymphoblastic leukaemia (Interfant-99): an observational study and a multicentre randomised trial","volume":"370","author":"Pieters","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.bbmt.2008.10.015_bib4","doi-asserted-by":"crossref","first-page":"3749","DOI":"10.1182\/blood-2004-08-3312","article-title":"Allogeneic hematopoietic cell transplantation for infants with acute lymphoblastic leukemia","volume":"105","author":"Sanders","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2008.10.015_bib5","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1016\/S0140-6736(02)08782-2","article-title":"Outcome of treatment in childhood acute lymphoblastic leukaemia with rearrangements of the 11q23 chromosomal region","volume":"359","author":"Pui","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.bbmt.2008.10.015_bib6","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1038\/sj.leu.2402883","article-title":"Clinical heterogeneity in childhood acute lymphoblastic leukemia with 11q23 rearrangements","volume":"17","author":"Pui","year":"2003","journal-title":"Leukemia"},{"key":"10.1016\/j.bbmt.2008.10.015_bib7","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1182\/blood.V90.2.479","article-title":"Juvenile myelomonocytic leukemia","volume":"90","author":"Arico","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2008.10.015_bib8","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1038\/bjc.1994.431","article-title":"Neurofibromatosis and childhood leukaemia\/lymphoma: a population-based UKCCSG study","volume":"70","author":"Stiller","year":"1994","journal-title":"Br J Cancer"},{"key":"10.1016\/j.bbmt.2008.10.015_bib9","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/ng0296-144","article-title":"Loss of NF1 results in activation of the Ras signaling pathway and leads to aberrant growth in murine and human hematopoietic cells","volume":"12","author":"Bollag","year":"1996","journal-title":"Nat Genet"},{"key":"10.1016\/j.bbmt.2008.10.015_bib10","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1182\/blood-2005-11-011486","article-title":"Interstitial uniparental isodisomy at clustered breakpoint intervals is a frequent mechanism of NF1 inactivation in myeloid malignancies","volume":"108","author":"Stephens","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2008.10.015_bib11","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S1097-2765(00)80415-3","article-title":"Nf1 and Gmcsf interact in myeloid leukemogenesis","volume":"5","author":"Birnbaum","year":"2000","journal-title":"Mol Cell"},{"key":"10.1016\/j.bbmt.2008.10.015_bib12","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1086\/340847","article-title":"PTPN11 mutations in Noonan syndrome: molecular spectrum, genotype-phenotype correlation, and phenotypic heterogeneity","volume":"70","author":"Tartaglia","year":"2002","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.bbmt.2008.10.015_bib13","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1182\/blood-2003-09-3287","article-title":"Mutations in PTPN11 implicate the SHP-2 phosphatase in leukemogenesis","volume":"103","author":"Loh","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2008.10.015_bib14","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1073\/pnas.0307203101","article-title":"Somatic activation of oncogenic Kras in hematopoietic cells initiates a rapidly fatal myeloproliferative disorder","volume":"101","author":"Braun","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bbmt.2008.10.015_bib15","doi-asserted-by":"crossref","first-page":"4243","DOI":"10.1182\/blood-2003-08-2650","article-title":"Somatic inactivation of Nf1 in hematopoietic cells results in a progressive myeloproliferative disorder","volume":"103","author":"Le","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2008.10.015_bib16","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s11864-003-0021-z","article-title":"Juvenile myelomonocytic leukemia","volume":"4","author":"Niemeyer","year":"2003","journal-title":"Curr Treat Options Oncol"},{"key":"10.1016\/j.bbmt.2008.10.015_bib17","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1182\/blood.V77.5.925.925","article-title":"Selective hypersensitivity to granulocyte-macrophage colony stimulating factor by juvenile chronic myeloid\u00a0leukemia hematopoietic progenitors","volume":"77","author":"Emanuel","year":"1991","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2008.10.015_bib18","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1182\/blood.V91.1.365","article-title":"Differentiating juvenile myelomonocytic leukemia from infectious disease","volume":"91","author":"Pinkel","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2008.10.015_bib19","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.ccr.2008.08.014","article-title":"Single cell profiling identifies aberrant STAT5 activation in myeloid malignancies with specific clinical and biologic correlates","volume":"14","author":"Kotecha","year":"2008","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbmt.2008.10.015_bib20","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1002\/1097-0142(1984)54:4<675::AID-CNCR2820540415>3.0.CO;2-Q","article-title":"Subacute and chronic myelomonocytic leukemia in children (juvenile CML)","volume":"54","author":"Castro-Malaspina","year":"1984","journal-title":"Cancer"},{"key":"10.1016\/j.bbmt.2008.10.015_bib21","first-page":"434","article-title":"Prospective study of 90 children requiring treatment for juvenile myelomonocytic leukemia or myelodysplastic syndrome: a report from the Children's Cancer Group","volume":"20","author":"Woods","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2008.10.015_bib22","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1182\/blood-2004-05-1944","article-title":"Hematopoietic stem cell transplantation (HSCT) in children with juvenile myelomonocytic leukemia (JMML): results of the EWOG-MDS\/EBMT trial","volume":"105","author":"Locatelli","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2008.10.015_bib23","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1056\/NEJM199412223312503","article-title":"A pilot study of isotretinoin in the treatment of juvenile chronic myelogenous leukemia","volume":"331","author":"Castleberry","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bbmt.2008.10.015_bib24","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1182\/blood-2007-06-093302","article-title":"Development of an\u00a0allele-specific minimal residual disease assay for patients with juvenile myelomonocytic leukemia","volume":"111","author":"Archambeault","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2008.10.015_bib25","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1200\/JCO.2000.18.2.340","article-title":"Comparison of preparative regimens in transplants for children with acute lymphoblastic leukemia","volume":"18","author":"Davies","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2008.10.015_bib26","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1002\/pbc.21207","article-title":"Long-term follow-up of children who underwent hematopoietic cell transplant (HCT) for AML or ALL at less than 3 years of age","volume":"49","author":"Perkins","year":"2007","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.bbmt.2008.10.015_bib27","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1038\/sj.leu.2401818","article-title":"Late effects in survivors of infant leukemia","volume":"14","author":"Leung","year":"2000","journal-title":"Leukemia"},{"key":"10.1016\/j.bbmt.2008.10.015_bib28","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1200\/JCO.1997.15.6.2238","article-title":"Late effects of allogeneic bone marrow transplantation for children with acute myeloblastic leukemia in first complete remission: the impact of conditioning regimen without total-body irradiation\u2014a report from the Societe Francaise de Greffe de Moelle","volume":"15","author":"Michel","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2008.10.015_bib29","doi-asserted-by":"crossref","first-page":"5515","DOI":"10.1182\/blood-2007-10-117150","article-title":"Twenty-five-year follow-up among survivors of childhood acute lymphoblastic leukemia: a report from the Childhood Cancer Survivor Study","volume":"111","author":"Mody","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2008.10.015_bib30","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1002\/cncr.23405","article-title":"Twenty years of follow-up among survivors of childhood and young adult acute myeloid leukemia: a report from the Childhood Cancer Survivor Study","volume":"112","author":"Mulrooney","year":"2008","journal-title":"Cancer"}],"container-title":["Biology of Blood and Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879108004515?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879108004515?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:34:27Z","timestamp":1761057267000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1083879108004515"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,1]]}},"alternative-id":["S1083879108004515"],"URL":"https:\/\/doi.org\/10.1016\/j.bbmt.2008.10.015","relation":{},"ISSN":["1083-8791"],"issn-type":[{"type":"print","value":"1083-8791"}],"subject":[],"published":{"date-parts":[[2009,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Controversies of and Unique Issues in Hematopoietic Cell Transplantation for Infant Leukemia","name":"articletitle","label":"Article Title"},{"value":"Biology of Blood and Marrow Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbmt.2008.10.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}